JPH03103176A - Pyrimidine nucleoside phosphorylase and production thereof - Google Patents
Pyrimidine nucleoside phosphorylase and production thereofInfo
- Publication number
- JPH03103176A JPH03103176A JP24085689A JP24085689A JPH03103176A JP H03103176 A JPH03103176 A JP H03103176A JP 24085689 A JP24085689 A JP 24085689A JP 24085689 A JP24085689 A JP 24085689A JP H03103176 A JPH03103176 A JP H03103176A
- Authority
- JP
- Japan
- Prior art keywords
- minutes
- pyrimidine nucleoside
- nucleoside phosphorylase
- temperature
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- 102000001853 Pyrimidine Phosphorylases Human genes 0.000 title claims description 24
- 108010054917 Pyrimidine Phosphorylases Proteins 0.000 title claims description 23
- 230000009471 action Effects 0.000 claims abstract description 9
- 239000002718 pyrimidine nucleoside Substances 0.000 claims abstract description 7
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 6
- YXJDFQJKERBOBM-TXICZTDVSA-N alpha-D-ribose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O YXJDFQJKERBOBM-TXICZTDVSA-N 0.000 claims abstract description 4
- 238000001962 electrophoresis Methods 0.000 claims abstract description 4
- 238000002523 gelfiltration Methods 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims abstract description 4
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 3
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims abstract description 3
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims abstract description 3
- 229940104302 cytosine Drugs 0.000 claims abstract description 3
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 230000005764 inhibitory process Effects 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 230000002779 inactivation Effects 0.000 claims description 2
- 239000011565 manganese chloride Substances 0.000 claims description 2
- 235000002867 manganese chloride Nutrition 0.000 claims description 2
- 229940099607 manganese chloride Drugs 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 abstract description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract description 3
- 150000007523 nucleic acids Chemical class 0.000 abstract description 3
- 102000039446 nucleic acids Human genes 0.000 abstract description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 3
- 230000009849 deactivation Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 48
- 239000000243 solution Substances 0.000 description 32
- 229910000160 potassium phosphate Inorganic materials 0.000 description 24
- 235000011009 potassium phosphates Nutrition 0.000 description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 16
- 239000011780 sodium chloride Substances 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical compound [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N Hypoxanthine Natural products O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108030006145 Pyrimidine-nucleoside phosphorylases Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野〉
本発明は新規なピリミジンヌクレオシドホスホリラーゼ
およびその製造方法に関する.(従来の技術〉
ピリミジンヌクレオシドホスホリラーゼは、医薬品とし
て注目されている核酸の製造に有用な酵素である.
これまでに、ピリミジンヌクレオシドホスホリラーゼに
関する報告は次のようなものがある.1.P.P.Sa
unders,B.A.Wilson and G
.F.Saunders.,J.Biol.Chem.
244.3691(1967)
2.E.W.Yamada.,J.B i o l .
Chem.243.1649 (1968)3.J.J
.Scocca.,J.Biol.Chem.246.
6606 (1971)(発明が解決しようとする課題
)
しかし、前述のピリミジンヌクレオシドホスホリラーゼ
は耐熱性が低いものであった.本発明者らはこれまでに
知られているピリミジンヌクレオシドホスホリラーゼよ
り、耐熱性にすぐれ、反応速度が速い新規な酵素を提供
すること?目的として、鋭意研究を進めた.
(問題点を解決するための手段〉
本発明のピリミジンヌクレオシドホスホリラーゼは以下
の性質を有する.
■作用:ピリミジンヌクレオシド + リン酸■塩基
+ リボースーl−リン酸
■基質特異性:シチジン、シトシン、およびその誘導体
以外のピリミジンヌクレオシドと塩基に対して作用する
.
■至適pHおよび安定pH
至適ρHはpH7〜l1
pH4.5 〜10.5において70℃の処理を30分
しても失活しない.
■至適温度および作用適温の範囲
至適温度;70℃
pH7.0において50〜70℃では60分処理をして
も安定
pH7.0、70℃における半減期:
l5.1時間
■+pH、温度などによる失活の条件:pH7.0、8
0℃で処理したとき60分で失活する.
■阻害、活性化および安定化
特別な活性化剤や安定化剤を必要としない.塩化マンガ
ンにより阻害を受ける.
■分子量: 85000 (TSKゲルG−3000S
Wによるゲル枦過法)
■サブユニットの分子量
54000 (SDS電気泳動法)
本発明のピリミジンヌクレオシドホスホリラーゼは至適
pHおよび安定pH、至適温度および作用適温の範囲に
おいて、これまでに知られているものと性質を異にして
いる.
次に本発明の酵素の製造法について説明する.本発明に
おいて用いられる該酵素生産菌の好ましい例として本発
明者らによって土壌中より分離されたバチルス・ステア
ロサーモフィルス/lty ci//l.! 5711
lθl7etz77p7i/〃s) J T S 8
5 9がある.この菌株は、通商産業省工業技術院微生
物工業研究所に寄託されており、その寄託番号は、微工
研菌寄第9666号(FERM P−9666)であ
る.
この菌株の菌学的性質をパージエイズ・マニュアル第2
巻に準じて検討した結果を以下に示す.1,形態
桿菌=5.4〜6.5μmX0.7〜0.9μ m
楕円形の胞子形成=2.0〜2.3μm×1.1〜1.
2μm、1m胞
に1個、位置は末端
2.培養的性質
NB培地:62℃、2日間培養
平板上:白色僅かに黄色を含む.光沢あり,不透明、盛
り上がらない.コロニ
ーの形は円形波状
スラント上:白色僅がに黄色を含む.光沢あり、不透明
、盛り上がらな
い.生育は中程度
3.生化学的性質
1 グラム染色
陽性
2 嫌気的培養
3 運動性
4 オキシダーゼ
5 カタラーゼ
6 ゼラチンの液化
7 リトマスミルク
8 0Fテスト
9V−Pテスト
10 グルコースからの
ガスの発生
l1 グルコースからの
酸の産生
12 アラビノースからの
酸の産生
13 マニトールからの
酸の産生
14 キシロースからの
酸の産生
15 サブロー培地での生育
スラント
生育せず
あり、周毛
陽性
陽性
液化能あり
凝固させる
醗酵タイプ
陰性
発生せず
産生した
産生ぜず
産土した
産生ぜず
生育した
液体 生育した
16 0.001%リゾチーム
下での生育 生育せず
17 0.02%アジ化物
下での生育 生育せず
18 7%NaCl
下での生育 生育せず
(2%まで生育した)
19 カゼインの加水分解 分解能あり20 デン
プンの加水分解 分解能あり21 ジヒドロキシア
セトン
の生成 生成せず
22 エッグヨーク試験 生育せず23 クエン
酸の利用 陰性
24 インドールの産生 陰性
25 ウレアーゼ活性 陽性
26 フェニルアラニンの
脱アミノ化 陰性
27 アルギニンデヒドロ
ラーゼ活性 陽性1
28 チロシンの分解 陰性
29 レバン産生 陰性
30 w4酸塩の還元 陽性31 硝酸ナ
トリウムの
脱窒能 陰性
32 硫化水素の生成 陽性
33 無機窒素源の利用
N O xを唯一の
窒素源として 生育した
NH.を唯一の
窒素源として 生育した
34 0C含量 47.3%35 生
育温度 40〜71℃で生育最適 60〜68℃
36 ρH範囲 pH5.7〜8.5最適pH6
.0〜7.0
以上の性質に基づき、本株菌はバチルス・ステアロサー
モフィルス/liri//tts sh/7rρ//I
IIIρβIi/VS)と同定される.
上記株菌の培養は、バチルス・ステアロサーモフィルス
の通常行われる条件で良い.好ましくは培地に窒素源と
して、トリプトン、ベプトンまたはカザミノ酸を、炭素
源としてグルコースまたはスクロースを含み、さらに酵
母エキスと塩化ナトリウムを含む培地を用い、60〜6
5℃、180〜22Orpm7′振とう培養するか、通
気攪拌培養による条件が良い.
また、本発明における使用菌としては、バチルス・ステ
アロサーモフィルスJTS859だけでなく、バチルス
属に属する前記した機能を持つピリミジンヌクレオシド
ホスホリラーゼを生産する微生物であればすべて用いる
ことができる.培養物よりピリミジンヌクレオシドホス
ホリラーゼを採取する方法は定法に従って行えば良い.
一例として、集菌した菌体を破壊した後、熱処理、アセ
トン処理、pH処理を順次ほどこし、ついで・DEAE
(ジエチルアミノエチル)陽イオン樹脂力ラム,ブチ
ル基疎水クロマト力ラム、およびゲル枦過を行う方法を
示すことができる.本発明のピリミジンヌクレオシドホ
スホリラーゼを用い、ビリミジン塩基とリボース−1−
リン酸からピリミジンヌクレオシドを効率よく製造する
ことができる.以下、本発明の実施例を示し、さらに詳
しく説明する.
(実施例1)バチルス・ステアロサーモフイルス(Ea
cj//us.stearothermophjノ//
s)JTS859の培養、集菌ベプトン20g、イース
トエキス10g、グルコース3g、塩化ナトリウム3g
および水11よりなるpH6.0の培地を用いた.この
培地2Iにバチルス・ステアロサーモフィルスJTS8
59の胞子3.2X10’個を添加し、攪拌K(直径6
0m、上下部各6枚)を有するジャーファメンターを用
い、攪拌翼を680rpmで回転させつつ、通気Jil
.5vvm、培養温度65℃、pH5.9〜6.2で8
時間培養した.
培養終了後、菌体を遠心分離(10000g.4℃,1
5分〉により集菌した.
(実施例2)酵素の分離精製
得られた湿菌160gを2 0 m Mリン酸カリウム
(pH7.0、以下「緩衝液」という)に懸濁し,ダイ
ノミル(Willy A.Bachofen社製、ス
イス)で菌体を破壊した.[衡液を添加し,、1 4
0 0 mlとした後、遠心分M(8300g、20分
)を行い、上清1300mlを得た.沈澱物は5 0
0 mlの緩衡液で懸濁し、ダイモミルで5分間処理し
た.緩衡液を添加し、1030mlとした後、遠心分離
(8300g、20分)を行い、上清990mlを得た
.この上清990mlを先の上清1300mlと合わせ
、63℃で1時間桜やかに攪拌した.ついで、遠心分離
(8300g.40分)を行い.上清2130mlを得
た.熱処理をした上清2130mlに、アセトン200
mlと緩衝液200mlの混合溶液(−10℃)を添加
した.さらに、−10℃のアセトン1.81を加え、5
〜10℃でl5分間攪拌した.つぎに、遠心分離(90
00g、5分)を行なった.得られた上清に−10℃の
アセトン2.51を添加し15分間攪拌した後、遠心分
離(9000g、5分〉を行ない沈澱物を得た.この沈
澱物を800mlの緩衝液に懸濁させアセトン処理済み
酵素液85 0 mlを得た.
アセトン処理済み酵素液850mlにIMリン酸を加え
、ρHを4.75として1時間O℃に保った.遠心分離
(8900g、1時間)を行い、上清を得た.この上清
にIMの水酸化カリウムを加え、pHを7.0に調整し
840mlの酵素液を得た.
得られた酵素液8 4 0 mlをDEAE Toy
opearl 650M(東ソー製)200mlを充
填したカラム(Φ45X126m)に添加した.ついで
20mMのリン酸カリウム緩衝液(pH7.0)2Mで
溶出を行い、ついで20mMリン酸カリウムとO.O’
5M、0.1M,0.15M、0.2M、0、5Mの塩
化ナトリウムよりなるpH7.0の溶液各11を順次用
いて溶出を行った.次に20mMリン酸カリウム、O.
IM塩化ナトリウム溶液の溶出画分11に本酵素活性を
見出だした.得られた溶出画分に同量の20mMリン酸
カリウム溶液(pH7.0)を加えた後、IM水酸化カ
リウム溶液でpH8.0にした.この溶液をDEAE
Toyopearl 650M(東ソー製>450
mlを充填したカラム(Φ31×53園)に添加した.
さらに、20mMリン酸カリウムと50mM塩化ナトリ
ウムよりなる溶液(pH8.0)lNと、20mMリン
酸カリウム溶液と2 0 0 m M塩化ナトリウムよ
りなる溶液(pH8.0)IJとで塩化ナトリウム濃度
の増加するグラジエントを作り、溶出し、176mlの
活性画分を得た.この両分に硫安27.9gを添加した
後、水酸化カリウムでpHを7.0に調節した. この
溶液を、1.2MilEE安と20mMリン酸カリウム
よりなる溶液(pH7.0)であらかじめ平衡化したB
utyl toyopearl 650S(東ソー
製)100ml(Φ16X300m)のカラムに添加し
、1.2MI安と20mMリン酸カリウムよりなる溶液
(pH7.0)100mlで溶出した.
さらに、1.2M硫安と20mMリン酸カリウムよりな
る溶液250mlと20mMリン酸カリウム溶液( p
H 7 . 0 ) 2 5 0 a+1とで硫安濃
度の減少するグラジエントを作り、溶出した.活性画分
75mlを分取し、20mMリン酸カリウム溶液に対し
透析後、限外枦過で14.2a+lに濃縮した.
得られた活性区分14.2mlを0.2Mリン酸カリウ
ム溶液(pH7.0)に対して透析した後、限外が過に
より7mlに濃縮した.
得られた溶液を20mMリン酸カリウム溶液(pH7.
0・)で平衡化したDEAE−5PW〈東ソー製、Φ7
.5X75m)に添加した.次いで、20mMカリウム
および50mM塩化ナトリウムよりなる溶液(pH8.
0)と、20mMリン酸カリウムおよび225mM塩化
ナトリウムよりなる溶液(ρH8.0)を用いて、塩化
ナトリウム濃度が増加するグラジエントにより流速1m
1/分で溶出した.
得られた溶液を0.2Mリン酸カリウム溶液(pH6.
8)で平衡化したTSKgel−G3ooosw(東ソ
ー製、Φ7.5X750肩)に添加した.次いで、0.
2Mリン酸カリウム溶液(pH6.8)を用い、流速0
.5ml/分で溶出し、本発明のピリミジンヌクレオシ
ドホスホリラーゼ12.1mgを得た.
(実施例3)理化学的性質
■作用および基質特異性
本発明のピリミジンヌクレオシドホスホリラーゼ0.1
4μgを含む20mMヌクレオシド20mMリン酸カリ
ウム溶液(pH7.0)250μ1を60℃で20分間
反応させ、生成した1=基を定量した.結果を表1に示
す.
また本発明のピリミジンヌクレオシドホスホリラーゼ0
.14μg、20mM塩基、20mMリボース−1−リ
ン酸および20mMリン酸カリウムよりなる溶液(pH
7.0)250μ1を60℃で20分間反応させ、生成
したヌクレオシドを定量した.結果を表・2に示す.
表1
表2
(以下余白)
■至適pHおよび安定pH
本発明のピリミジンヌクレオシドホスボリラーゼ0.5
5μgを含む20mMS−メチルウリジン、20mMリ
ン酸カリウム溶液(pH3.0〜13)lmjlを60
’Cで20分間反応させ、生成したヒボキサンチンを測
定した.結果を図1に示す.
pH7から11.5の間において高い酵素活性がz2め
られた.
安定p}Iを調べるために本発明のピリミジンヌクレオ
シドホスホリラーゼ0.55μgを90μ1の20mM
クエン酸緩衡液(20mMリン酸カリウムを含む)、2
0mMグリシン緩衡液(20mMリン酸カリウムを含む
).20mMl−リス・塩酸M衡液(20mMリン酸カ
リウムを含む)、20mMリン酸カリウム緩衝液中各々
70℃で30分間加熟処理した後、残存する酵素活性を
定量した.結果を図2に示す.
酵素活性はpH6.5〜10.5において、失活しなか
った.
■至適温度および作用適温の範囲
本発明のピリミジンヌクレオシドホスホリラーゼ0.5
5μgを含む20mMS−メチルウリジン、20mMリ
ン酸カリウム溶液(pH7.0)1 mlを40〜80
℃で反応させ、生戒したヒボキサンチンを定量した.結
果を図3に示す.70℃以下では温度が高いほど生成速
度が速く、80℃では30分以内に酵素が失活した.ま
た、2’OmMリン酸カリウム溶液(pH7.0)中で
の酵素の半減期は、図4に示ように70℃において15
.1時間であった.
■阻害、活性化および安定化
本発明のピリミジンヌクレオシドホスホリラーゼ0.5
5μgを含む20mMS−メチルウリジン、20mMリ
ン酸カリウム溶液と1mMの各種金属イオン溶液(pH
7.0>lmlを60℃で20分反応させ,生成したヒ
ボキサンチンを定量した.
M g S O a ・7 H t O、H g C
I z . C u S O.−5H.O、ZnSO4
・7H2 0,CHx ICOOH.EDTA、パラク
ロロメルクリベンゾエイトでは阻害は認められなかった
が、Mn(12・4H20では強い阻害が認められた.
■分子量
TSKゲルG−3000SW(東ソーM)によるゲルP
過法では85000であった.SDS電気泳動法による
サブユニットの分子量は54000であった.
■アミノ酸組成
アミノ酸アナライザー(日立製H835)により分析し
た.結果を表3に示す.
表3
(発明の効果》
本発明のピリミジンヌクレオシドホスホリラーゼにより
塩基より核酸を容易に得ることができる.Detailed Description of the Invention (Industrial Field of Application) The present invention relates to a novel pyrimidine nucleoside phosphorylase and a method for producing the same. (Prior Art) Pyrimidine nucleoside phosphorylase is useful for producing nucleic acids, which are attracting attention as pharmaceuticals. It is an enzyme. To date, there are the following reports regarding pyrimidine nucleoside phosphorylase: 1.P.P.Sa
unders, B. A. Wilson and G.
.. F. Saunders. , J. Biol. Chem.
244.3691 (1967) 2. E. W. Yamada. , J. B i o l .
Chem. 243.1649 (1968) 3. J. J
.. Scocca. , J. Biol. Chem. 246.
6606 (1971) (Problem to be Solved by the Invention) However, the above-mentioned pyrimidine nucleoside phosphorylase had low thermostability. The purpose of the present inventors is to provide a new enzyme that has better heat resistance and faster reaction rate than the previously known pyrimidine nucleoside phosphorylases. With this goal in mind, we carried out intensive research. (Means for solving the problems) The pyrimidine nucleoside phosphorylase of the present invention has the following properties: ■Action: Pyrimidine nucleoside + phosphate ■Base
+ Ribose l-phosphate ■Substrate specificity: Acts on pyrimidine nucleosides and bases other than cytidine, cytosine, and their derivatives. ■Optimal pH and stable pH The optimum ρH is not inactivated even after 30 minutes of treatment at 70°C at pH 7-11 and pH 4.5-10.5. ■Optimum temperature and range of action temperatureOptimum temperature: 70℃ At pH 7.0, stable even after 60 minutes of treatment at 50-70℃pH 7.0, half-life at 70℃: 15.1 hours■+pH, temperature Conditions for inactivation: pH 7.0, 8
When treated at 0°C, it becomes inactive in 60 minutes. ■Inhibition, activation and stabilization No special activators or stabilizers are required. Inhibited by manganese chloride. ■Molecular weight: 85000 (TSK gel G-3000S
(Gel filtration method using W) ■Molecular weight of subunit: 54,000 (SDS electrophoresis method) The pyrimidine nucleoside phosphorylase of the present invention has a known range of optimal pH, stable pH, optimal temperature, and optimal temperature for action. It has different properties from things. Next, the method for producing the enzyme of the present invention will be explained. A preferred example of the enzyme-producing bacterium used in the present invention is Bacillus stearothermophilus/lty ci//l., which was isolated from soil by the present inventors. ! 5711
lθl7etz77p7i/〃s) J T S 8
There are 5 9. This strain has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, and its deposit number is FERM P-9666. The mycological properties of this strain were determined in Purge Aids Manual No. 2.
The results of the study according to the volume are shown below. 1. Morphology of rods = 5.4-6.5 μm x 0.7-0.9 μm Oval spore formation = 2.0-2.3 μm x 1.1-1.
2μm, 1 per 1m cell, located at the terminal 2. Culture properties: NB medium: 62°C, 2 days culture on plate: white with a slight yellow tinge. Shiny, opaque, and non-raised. Colony shape is circular wavy slant: white with a slight yellow tinge. Shiny, opaque, and not raised. Growth is medium 3. Biochemical properties 1 Positive Gram stain 2 Anaerobic culture 3 Motility 4 Oxidase 5 Catalase 6 Liquefaction of gelatin 7 Litmus milk 8 0F test 9 V-P test 10 Gas production from glucose 11 Acid production from glucose 12 From arabinose 13 Production of acid from mannitol 14 Production of acid from xylose 15 Growth in Sabouraud medium No slant growth, positive for pericilla, positive for liquefaction, coagulating fermentation type, negative for production, no production Liquid grown without producing soil Grows 16 Growth under 0.001% lysozyme No growth 17 Growth under 0.02% azide No growth 18 Growth under 7% NaCl No growth (2 19 Casein hydrolysis Degradation ability 20 Starch hydrolysis Degradation ability 21 Dihydroxyacetone production No production 22 Egg yoke test No growth 23 Utilization of citric acid Negative 24 Indole production Negative 25 Urease activity Positive 26 Deamination of phenylalanine Negative 27 Arginine dehydrolase activity Positive 1 28 Decomposition of tyrosine Negative 29 Levan production Negative 30 Reduction of w4 salts Positive 31 Denitrification ability of sodium nitrate Negative 32 Production of hydrogen sulfide Positive 33 Utilization of inorganic nitrogen sources N NH grown using Ox as the sole nitrogen source. 34 grown using as the sole nitrogen source OC content 47.3%35 Growth temperature Optimum growth at 40-71°C 60-68°C 36 ρH range pH 5.7-8.5 Optimum pH 6
.. 0 to 7.0 Based on the above properties, this strain is Bacillus stearothermophilus /liri//tts sh/7rρ//I
IIIρβIi/VS). The above strains may be cultured under the conditions normally used for Bacillus stearothermophilus. Preferably, the medium contains tryptone, veptone, or casamino acid as a nitrogen source, glucose or sucrose as a carbon source, and further contains yeast extract and sodium chloride.
Conditions such as 5°C, 180-22 Orpm 7' shaking culture or aerated agitation culture are best. In addition, the microorganism used in the present invention is not limited to Bacillus stearothermophilus JTS859, but any microorganism belonging to the genus Bacillus that produces pyrimidine nucleoside phosphorylase having the above-mentioned functions can be used. Pyrimidine nucleoside phosphorylase can be collected from culture according to standard methods.
As an example, after destroying the collected bacteria, heat treatment, acetone treatment, and pH treatment are sequentially applied, and then DEAE
(Diethylaminoethyl) cation resin ram, butyl group hydrophobic chromatography ram, and gel filtration methods can be shown. Using the pyrimidine nucleoside phosphorylase of the present invention, pyrimidine base and ribose-1-
Pyrimidine nucleosides can be efficiently produced from phosphoric acid. Hereinafter, examples of the present invention will be shown and explained in more detail. (Example 1) Bacillus stearothermophilus (Ea
cj//us. stearothermophjノ//
s) Culture of JTS859, 20g of bacterial collection, 10g of yeast extract, 3g of glucose, 3g of sodium chloride
A medium with a pH of 6.0 consisting of 11% and 11% water was used. Bacillus stearothermophilus JTS8 in this medium 2I
Add 3.2 x 10' of 59 spores and mix with K (diameter 6
Using a jar fermenter with 0m, 6 pieces each on the upper and lower parts, while rotating the stirring blades at 680 rpm,
.. 8 at 5vvm, culture temperature 65℃, pH 5.9-6.2
Cultured for hours. After culturing, the bacterial cells were centrifuged (10,000g, 4℃, 1
Bacteria were collected for 5 minutes. (Example 2) Separation and purification of enzymes 160 g of the obtained wet bacteria was suspended in 20 m M potassium phosphate (pH 7.0, hereinafter referred to as "buffer"), and Dynomil (manufactured by Willy A. Bachofen, Switzerland) was used. The bacterial cells were destroyed. [Add the equilibrated liquid, 1 4
After reducing the volume to 0.0 ml, centrifugation M (8300 g, 20 minutes) was performed to obtain 1300 ml of supernatant. The precipitate is 50
The suspension was suspended in 0 ml of buffer solution and treated with Dymomil for 5 minutes. After adding a buffer solution to bring the volume to 1030 ml, centrifugation (8300 g, 20 minutes) was performed to obtain 990 ml of supernatant. 990 ml of this supernatant was combined with 1300 ml of the previous supernatant and stirred gently at 63° C. for 1 hour. Then, centrifugation (8300g, 40 minutes) was performed. 2130 ml of supernatant was obtained. Add 200ml of acetone to 2130ml of heat-treated supernatant.
ml and 200 ml of buffer solution (-10°C) was added. Furthermore, add 1.81 liters of acetone at -10°C,
Stir for 15 minutes at ~10°C. Next, centrifugation (90
00g for 5 minutes). After adding 2.5 liters of acetone at -10°C to the obtained supernatant and stirring for 15 minutes, centrifugation (9000 g, 5 minutes) was performed to obtain a precipitate. This precipitate was suspended in 800 ml of buffer. 850 ml of acetone-treated enzyme solution was obtained. IM phosphoric acid was added to 850 ml of acetone-treated enzyme solution, ρH was set to 4.75, and the mixture was kept at 0°C for 1 hour. Centrifugation (8900 g, 1 hour) was performed. A supernatant was obtained. IM potassium hydroxide was added to this supernatant and the pH was adjusted to 7.0 to obtain 840 ml of enzyme solution. 840 ml of the obtained enzyme solution was added to DEAE Toy.
It was added to a column (Φ45 x 126 m) packed with 200 ml of opearl 650M (manufactured by Tosoh). Elution was then carried out with 2M 20mM potassium phosphate buffer (pH 7.0), followed by 20mM potassium phosphate buffer (pH 7.0). O'
Elution was performed using 11 solutions each of pH 7.0 consisting of 5M, 0.1M, 0.15M, 0.2M, 0, and 5M sodium chloride in sequence. Then 20mM potassium phosphate, O.
The enzyme activity was found in fraction 11 eluted from IM sodium chloride solution. The same amount of 20 mM potassium phosphate solution (pH 7.0) was added to the obtained elution fraction, and the pH was adjusted to 8.0 with IM potassium hydroxide solution. Add this solution to DEAE
Toyopearl 650M (manufactured by Tosoh>450
It was added to a column (Φ31 x 53 mm) packed with ml. Furthermore, the sodium chloride concentration increased with a solution (pH 8.0) of 20mM potassium phosphate and 50mM sodium chloride (pH 8.0) and a solution (pH 8.0) of 20mM potassium phosphate and 200mM sodium chloride (IJ). A gradient was prepared and eluted to obtain 176 ml of active fraction. After adding 27.9 g of ammonium sulfate to both portions, the pH was adjusted to 7.0 with potassium hydroxide. This solution was pre-equilibrated with a solution (pH 7.0) consisting of 1.2 Mil EE ammonium and 20 mM potassium phosphate.
It was added to a 100 ml (Φ16 x 300 m) column of Toyopearl 650S (manufactured by Tosoh), and eluted with 100 ml of a solution (pH 7.0) consisting of 1.2 MI ammonium and 20 mM potassium phosphate. Furthermore, 250 ml of a solution consisting of 1.2 M ammonium sulfate and 20 mM potassium phosphate and a 20 mM potassium phosphate solution (p
H7. 0 ) 2 5 0 a+1 to create a gradient of decreasing ammonium sulfate concentration and elute. 75 ml of the active fraction was collected, dialyzed against 20 mM potassium phosphate solution, and concentrated to 14.2 a+l by ultrafiltration. 14.2 ml of the obtained active fraction was dialyzed against 0.2 M potassium phosphate solution (pH 7.0) and concentrated to 7 ml by ultrafiltration. The resulting solution was diluted with 20mM potassium phosphate solution (pH 7.
DEAE-5PW (manufactured by Tosoh, Φ7) equilibrated with
.. 5x75m). Then a solution consisting of 20mM potassium and 50mM sodium chloride (pH 8.
0) and a solution consisting of 20mM potassium phosphate and 225mM sodium chloride (ρH 8.0), the flow rate was 1 m with a gradient of increasing sodium chloride concentration.
It eluted at 1/min. The obtained solution was diluted with 0.2M potassium phosphate solution (pH 6.
8) was added to TSKgel-G3ooosw (manufactured by Tosoh, Φ7.5X750 shoulder). Then 0.
Using 2M potassium phosphate solution (pH 6.8), flow rate 0
.. Elution was performed at 5 ml/min to obtain 12.1 mg of the pyrimidine nucleoside phosphorylase of the present invention. (Example 3) Physical and chemical properties ■Action and substrate specificity Pyrimidine nucleoside phosphorylase of the present invention 0.1
250 μl of a 20 mM potassium phosphate solution (pH 7.0) containing 4 μg of nucleoside was reacted at 60° C. for 20 minutes, and the generated 1= group was quantified. The results are shown in Table 1. Furthermore, the pyrimidine nucleoside phosphorylase 0 of the present invention
.. 14μg, 20mM base, 20mM ribose-1-phosphate and 20mM potassium phosphate solution (pH
7.0) 250 μl was reacted at 60°C for 20 minutes, and the produced nucleoside was quantified. The results are shown in Table 2. Table 1 Table 2 (blank below) ■Optimal pH and stable pH Pyrimidine nucleoside phosphorylase of the present invention 0.5
60 lmjl of 20mM potassium phosphate solution (pH 3.0-13) containing 5μg of 20mMS-methyluridine
'C for 20 minutes, and the produced hyboxanthin was measured. The results are shown in Figure 1. High enzyme activity was observed between pH 7 and 11.5. To examine stable p}I, 0.55 μg of the pyrimidine nucleoside phosphorylase of the present invention was added to 90 μl of 20 mM
Citrate buffer (containing 20mM potassium phosphate), 2
0mM glycine buffer (contains 20mM potassium phosphate). After aging at 70°C for 30 minutes in 20mM Lis-HCl solution (containing 20mM potassium phosphate) and 20mM potassium phosphate buffer, the remaining enzyme activity was quantified. The results are shown in Figure 2. Enzyme activity was not inactivated at pH 6.5 to 10.5. ■Optimum temperature and range of temperature for action Pyrimidine nucleoside phosphorylase of the present invention 0.5
1 ml of 20mMS-methyluridine, 20mM potassium phosphate solution (pH 7.0) containing 5 μg was added to 40-80%
The reaction was carried out at ℃, and the released hypoxanthin was quantified. The results are shown in Figure 3. At temperatures below 70°C, the higher the temperature, the faster the production rate, and at 80°C, the enzyme was deactivated within 30 minutes. In addition, the half-life of the enzyme in 2'OmM potassium phosphate solution (pH 7.0) is 15 at 70°C as shown in Figure 4.
.. It was one hour. ■Inhibition, activation and stabilization of the pyrimidine nucleoside phosphorylase of the present invention 0.5
20mM MS-methyluridine containing 5μg, 20mM potassium phosphate solution and 1mM various metal ion solutions (pH
7.0>lml was reacted at 60°C for 20 minutes, and the produced hyboxanthin was quantified. M g S O a ・7 H t O, H g C
Iz. C u S O. -5H. O, ZnSO4
・7H2 0, CHx ICOOH. No inhibition was observed with EDTA and parachloromercribenzoate, but strong inhibition was observed with Mn(12.4H20).
■Gel P with molecular weight TSK gel G-3000SW (Tosoh M)
Under the law, it was 85,000. The molecular weight of the subunit by SDS electrophoresis was 54,000. ■Amino acid composition Analyzed using an amino acid analyzer (Hitachi H835). The results are shown in Table 3. Table 3 (Effects of the Invention) Nucleic acids can be easily obtained from bases using the pyrimidine nucleoside phosphorylase of the present invention.
第l図は本発明のピリミジンヌクレオシドホスホリラー
ゼのpH依存性を示す図面である.第2図は本発明のピ
リミジンヌクレオシドホスホリラーゼのpH安定性を示
す図面である.第3図は作用適温の範囲を示す図面であ
る.第4図は酵素活性の半減期を示す図面である.出即
人 日本たばこ産業株式会社
残゛存58姓(γ。)
O
会
0
Φ
0
CO
O
0
0
チミン
(mM)
千$ン
(mM)FIG. 1 is a drawing showing the pH dependence of the pyrimidine nucleoside phosphorylase of the present invention. FIG. 2 is a diagram showing the pH stability of the pyrimidine nucleoside phosphorylase of the present invention. Figure 3 is a diagram showing the range of suitable temperature for action. Figure 4 is a diagram showing the half-life of enzyme activity. Origin: Japan Tobacco Inc. 58 remaining surnames (γ.)
Claims (1)
ホスホリラーゼ (1)作用:ピリミジンヌクレオシド+リン酸⇔塩基+
リボース−1− リン酸 (2)基質特異性:シチジン、シトシン、およびその誘
導体以外のピリミジンヌクレオシドと塩基に対して作用
する。 (3)至適pHおよび安定pH 至適pHはpH7〜11 pH6.5〜10.5において70℃の処 理を30分しても失活しない。 (4)至適温度および作用適温の範囲 至適温度は70℃、pH7.0において50〜70℃で
は60分処理をしても安定 (5):pH、温度などによる失活の条件:pH7.0
、80℃で処理したとき60分 で失活する。 (6)阻害、活性化および安定化 特別な活性化剤や安定化剤を必要としない。 塩化マンガンにより阻害を受ける。 (7)分子量:85000(TSKゲルG−3000S
Wによるゲル濾過法) (8)サブユニットの分子量 54000(SDS電気泳動法) 2、請求項1項に記載の酵素を生産する能力を有するバ
チルス属に属する微生物を培養し、培養物より該酵素を
採取することを特徴とするピリミジンヌクレオシドホス
ホリラーゼの製造方法。[Claims] 1. Pyrimidine nucleoside phosphorylase (1) having the following physical and chemical properties: pyrimidine nucleoside + phosphate ⇔ base +
Ribose-1-phosphate (2) Substrate specificity: Acts on pyrimidine nucleosides and bases other than cytidine, cytosine, and their derivatives. (3) Optimum pH and Stable pH The optimal pH is pH 7 to 11. At pH 6.5 to 10.5, it is not inactivated even after 30 minutes of treatment at 70°C. (4) Optimum temperature and range of action temperature The optimal temperature is 70°C, and at pH 7.0, it is stable even after 60 minutes of treatment at 50 to 70°C (5): Conditions for inactivation depending on pH, temperature, etc.: pH 7 .0
, it is deactivated in 60 minutes when treated at 80°C. (6) Inhibition, activation and stabilization No special activators or stabilizers are required. Inhibited by manganese chloride. (7) Molecular weight: 85000 (TSK gel G-3000S
(Gel filtration method using W) (8) Molecular weight of subunit: 54,000 (SDS electrophoresis method) 2. A microorganism belonging to the genus Bacillus having the ability to produce the enzyme according to claim 1 is cultured, and the enzyme is extracted from the culture. A method for producing pyrimidine nucleoside phosphorylase, which comprises collecting pyrimidine nucleoside phosphorylase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24085689A JP2565572B2 (en) | 1989-09-19 | 1989-09-19 | Pyrimidine nucleoside phosphorylase and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24085689A JP2565572B2 (en) | 1989-09-19 | 1989-09-19 | Pyrimidine nucleoside phosphorylase and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03103176A true JPH03103176A (en) | 1991-04-30 |
JP2565572B2 JP2565572B2 (en) | 1996-12-18 |
Family
ID=17065729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24085689A Expired - Lifetime JP2565572B2 (en) | 1989-09-19 | 1989-09-19 | Pyrimidine nucleoside phosphorylase and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2565572B2 (en) |
-
1989
- 1989-09-19 JP JP24085689A patent/JP2565572B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2565572B2 (en) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960014702B1 (en) | Acid urease and production thereof | |
JPH0329399B2 (en) | ||
JP3026857B2 (en) | Novel pullulanase and method for producing the same | |
JP3586684B1 (en) | Novel microorganisms that convert validamycin to valienamin and validamin | |
JP2672845B2 (en) | Method for producing L-alanine dehydrogenase | |
JPH03103176A (en) | Pyrimidine nucleoside phosphorylase and production thereof | |
EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
JPH03127985A (en) | L-carnitine dehydrogenase and production thereof | |
JPH01320995A (en) | Production of nucleoside compound | |
JP3735956B2 (en) | Xanthine dehydrogenase and method for producing the enzyme | |
JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
JP2544480B2 (en) | Purine nucleoside phosphorylase and method for producing the same | |
JP2548356B2 (en) | Brin nucleoside phosphorylase and method for producing the same | |
JPS61239887A (en) | L-phenylalanine dehydrogenase | |
JPH0616704B2 (en) | Bacterial catalase resistant to fluoride ions and Micrococcus sp. KWI-5 strain | |
JPS58152482A (en) | Heat-resistant proteolytic enzyme aqualysin i and preparation thereof | |
JP3012356B2 (en) | Manufacturing method of fructokinase | |
JPH0856666A (en) | Heat-resistant o-acetylserinesulfhydrylase and production | |
Yang et al. | Isolation and characterization of Enterobacter sp. producing galacto-oligosaccharides | |
JPS6318471B2 (en) | ||
JPS63313580A (en) | Formic acid dehydrogenase | |
JP2008167718A (en) | Method for producing novel uricase | |
JPH03133376A (en) | Production of sarcosine oxidase | |
JPH0630573B2 (en) | L-phenylalanine dehydrogenase and method for producing the same | |
JPH0428353B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081003 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091003 Year of fee payment: 13 |
|
EXPY | Cancellation because of completion of term |